Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7251 results

Sort By:

Tirzepatide Weight Loss for MRD+ Early Breast Cancer

Study ID: NCT06517212
Start Date: 2024-11-26
End Date: 2030-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

48

Intervention / Treatment

Tirzepatide

Sponsor

Baylor Research Institute

Source: clinicaltrials.gov

Share:
Add to list

Accurate, Rapid and Inexpensive MRI Protocol for Breast Cancer Screening

Study ID: NCT04877912
Start Date: 2020-09-17
End Date: 2024-09-14
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

200

Intervention / Treatment

MRI Abbreviated Scan

Abbreviated MRI Scan

Sponsor

University of Chicago

Source: clinicaltrials.gov

Share:
Add to list

Intraoperative Ansa Cervicalis Nerve (ACN) Stimulation

Study ID: NCT05650710
Start Date: 2023-02-28
End Date: 2026-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment

Nerve stimulation using nerve stimulation device and sterile wire electrode.

Sponsor

Vanderbilt University Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Excision of Lymph Node Trial (EXCILYNT) (Mel69)

Study ID: NCT05839912
Start Date: 2023-09-06
End Date: 2028-09-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

66

Intervention / Treatment

Excision of clinically detected lymph node metastasis before any systemic therapy

Excision of clinically detected lymph node metastasis after neoadjuvant systemic therapy

Sponsor

Craig L Slingluff, Jr

Source: clinicaltrials.gov

Share:
Add to list

REMASTer: REcurrent Brain Metastases After SRS Trial

Study ID: NCT05124912
Start Date: 2022-05-10
End Date: 2028-10
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

261

Intervention / Treatment

Radiation Therapy

Steroid Therapy

Laser Interstitial Thermal Therapy

Sponsor

Monteris Medical

Source: clinicaltrials.gov

Share:
Add to list

A Study of 177Lu-FAP-2286 in Advanced Solid Tumors

Study ID: NCT04939610
Start Date: 2021-07-30
End Date: 2028-06-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

222

Intervention / Treatment

68GA-FAP-2286

177Lu-FAP-2286

Sponsor

Novartis Pharmaceuticals

Source: clinicaltrials.gov

Share:
Add to list

Assessment of Remote Approaches for Identification of Autonomic Dysfunction Among Survivors of Leukemia and Lymphoma

Study ID: NCT06747910
Start Date: 2025-02-03
End Date: 2026-02
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

188

Intervention / Treatment

Exercise Intervention - Ewing Battery Assessment

Administration questionnaire

Medical Device Usage and Evaluation

Sponsor

St. Jude Children's Research Hospital

Source: clinicaltrials.gov

Share:
Add to list

Low-Dose Total Skin Electron Therapy in Treating Patients With Refractory or Relapsed Stage IB-IIIA Mycosis Fungoides

Study ID: NCT02702310
Start Date: 2016-05-22
End Date: 2026-09
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

Quality-of-Life Assessment

Objective Grading of Skin Findings

Sponsor

Vanderbilt-Ingram Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Prospective Randomized Study of Accelerated Radiation Therapy (PRART)

Study ID: NCT04175210
Start Date: 2019-11-21
End Date: 2030-02-28
Study Type

Interventional

Study Phase

Phase3

No. of Participants

400

Intervention / Treatment

Radiation therapy - 3 weeks

Radiation therapy - 2 weeks

Sponsor

Weill Medical College of Cornell University

Source: clinicaltrials.gov

Share:
Add to list

Refining Local-Regional Therapy for IBC

Study ID: NCT04636710
Start Date: 2021-06-02
End Date: 2028-12-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment

Lymphoscintigraphy

Sponsor

Dana-Farber Cancer Institute

Source: clinicaltrials.gov

Share:
Add to list